2020
DOI: 10.23937/2643-4571/1710020
View full text
|
|
Share
Dubuc César Antonio Egües,
Calvo-Alen Jaime,
Cabrera-Miranda Lizbeth Patricia
et al.

Abstract: Background: The mortality rate of Hemophagocytic Syndrome (HPS) is 26.5%-74.8%. Malignant neoplasms, hyperferritinemia, thrombocytopenia, older age, hypertriglyceridemia, and prolonged prothrombin are considered to be adverse prognostic factors. This study describes the underlying features of patient's survivors and non-survivors with HPS from one hospital between 2005-2019. Methodology: This is a retrospective study. We included patient with HPS diagnosis based on the HLH-2004 criteria, or who presented hemop…

Expand abstract

Search citation statements

Order By: Relevance

Paper Sections

0
0
0
0
0

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals